Recombinant Human Antithrombin (rhAT) in Patients With Hereditary Antithrombin Deficiency Undergoing Surgery or Delivery

Clinical trial NCT00110513 · COMPLETED

Trial details

NCT number: NCT00110513
Sponsor: rEVO Biologics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Antithrombin III Deficiency

Start date: 2005-04-01
Primary completion: 2008-05-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.